Prevenar (13v)
Pre-clinicalCompleted 0 views this week 0 watching💤 Quiet
Interest: 26/100
26
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Infants
Conditions
Infants
Trial Timeline
Mar 1, 2014 → May 1, 2016
NCT ID
NCT02119104About Prevenar (13v)
Prevenar (13v) is a pre-clinical stage product being developed by Pfizer for Infants. The current trial status is completed. This product is registered under clinical trial identifier NCT02119104. Target conditions include Infants.
What happened to similar drugs?
0 of 1 similar drugs in Infants were approved
Approved (0) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
3
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02119104 | Pre-clinical | Completed |
Competing Products
3 competing products in Infants
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| RotaTeq (V260) + IPV | Merck | Phase 3 | 40 |
| rhBSSL + Placebo | Swedish Orphan Biovitrum | Phase 2 | 35 |
| rhBSSL + Placebo | Swedish Orphan Biovitrum | Phase 2 | 35 |